Target intelligence / Profile preview

Cellular proteins and membranes

Molecular classification
Other
01

Overview

Cellular proteins and membranes in the context of osmoprotection refers to the collective structural and functional components of the cell that are shielded from damage during osmotic stress (Baudouin et al., 2013). In conditions such as dry eye disease, hyperosmolarity of the tear film creates an osmotic gradient that draws water out of corneal and conjunctival cells, leading to protein denaturation, membrane damage, and the activation of pro-inflammatory signaling pathways (Willcox et al., 2017). Osmoprotectants, such as levocarnitine, erythritol, and betaine, are utilized therapeutically to penetrate these cells and provide a stabilizing effect (Garrett et al., 2012). By acting as chemical chaperones, these molecules prevent protein misfolding and maintain the integrity of cellular membranes, thereby inhibiting the inflammatory cascade and apoptotic pathways triggered by osmotic imbalance (Chen et al., 2013). This target represents a holistic approach to cytoprotection rather than a single receptor-ligand interaction, focusing on the preservation of cellular homeostasis under environmental stress (Peluso et al., 2015). Preserving these components is critical for preventing the "vicious cycle" of inflammation and ocular surface damage associated with chronic hyperosmotic conditions.

Other names
Ocular surface proteins and membranesCellular structural componentsIntracellular macromolecules
02

Mechanism of action

Osmoprotectants accumulate intracellularly to balance osmotic pressure, acting as chemical chaperones to stabilize protein folding and maintain membrane integrity under hypertonic conditions.

03

Biological functions

OsmoprotectionCell volume regulationProtein stabilizationMembrane integrity maintenanceInhibition of apoptosis
04

Disease associations

Dry eye diseaseHyperosmotic stressKeratoconjunctivitis siccaOcular surface inflammation
05

Safety considerations

Transient blurred visionOcular stinging or irritationHypersensitivity reactions
06

Interacting drugs

Levocarnitine

4 more in the full profile.

07

Biomarkers

Tear osmolarityOcular Surface Disease Index (OSDI)Corneal fluorescein stainingConjunctival impression cytology (HLA-DR expression)

Beyond the preview

Go deeper on Cellular proteins and membranes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular proteins and membranes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call